Tag: Therapeutics
-
Vertex And CRISPR Therapeutics: Historic Exa-cel Approval, Why Market Is Nonplussed (VRTX)
Bet_Noire Investment Overview Historic Approval Validates CRISPR Gene Editing Approach News broke this afternoon that the Food and Drug Agency (“FDA”) has granted approval to a CRISPR-based gene editing therapy for the first time in history. It is an historic achievement for both Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and CRISPR Therapeutics AG (NASDAQ:CRSP), the two companies…
-
CRISPR Gene Editing: Intellia Vs CRISPR Therapeutics
vchal In my last article, CRISPR-Cas9 Gene Editing Is On The Cusp Of Something Big, I gave an overview of CRISPR-Cas9 and how exactly the science works. At the end of the article, I briefly mentioned the major players in the CRISPR space, including Intellia (NASDAQ:NTLA), CRISPR Therapeutics (NASDAQ:CRSP), Beam Therapeutics (BEAM), Editas Medicine (EDIT),…